Trials / Completed
CompletedNCT06621433
Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession
Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession: a Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Rizk Beshir · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the effectiveness of using titanium prepared platelet rich fibrin with coronally advanced flap in the treatment of type-2 Cairo gingival recession.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | T-PRF with CAF | Blood sample will be obtained from the patient, conveyed into a titanium tube and immediately centrifuged at 2700 rpm for 12 mins at room temperature using fixed angle centrifuge (PRF Process, Tangkula800-1, China). The fibrin clot will be collected and placed in the PRF compression device (PRF GRF box) and condensed to produce a uniform T-PRF membrane which will be inserted over the recession area and covered by the coronally advanced flap. |
| OTHER | SECTG with CAF | Sub epithelial connective tissue graft will be obtained from the donor site (hard palate), placed into recipient site and secured by sutures, then covered by a coronally advanced flap. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-01-20
- Completion
- 2024-01-22
- First posted
- 2024-10-01
- Last updated
- 2024-10-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06621433. Inclusion in this directory is not an endorsement.